Trial · NCT04621929
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Kidney Stone Size (mm^3) Determined by Non-contrast CAT Scan | Allocated to Intervention/Treatment | Baseline | 6540 | Standard Deviation 10430 | mm^3 |
| Kidney Stone Size (mm^3) Determined by Non-contrast CAT Scan | Allocated to Pragmatic Control | Baseline | 4650 | Standard Deviation 6064 | mm^3 |
| Kidney Stone Size (mm^3) Determined by Non-contrast CAT Scan | Allocated to Intervention/Treatment | End of Study (18 months) | 3120 | Standard Deviation 5158 | mm^3 |
| Kidney Stone Size (mm^3) Determined by Non-contrast CAT Scan | Allocated to Pragmatic Control | End of Study (18 months) | 5041 | Standard Deviation 7043 | mm^3 |
| Weight (kg) | Allocated to Intervention/Treatment | Baseline | 121.4 | Standard Deviation 24 | kg |
| Weight (kg) | Allocated to Pragmatic Control | Baseline | 101.2 | Standard Deviation 23 | kg |
| Weight (kg) | Allocated to Intervention/Treatment | End of Study (18 months) | 111.2 | Standard Deviation 24 | kg |
| Weight (kg) | Allocated to Pragmatic Control | End of Study (18 months) | 104.1 | Standard Deviation 26 | kg |
| Urinary pH Parameters | Allocated to Intervention/Treatment | Baseline | 5.3 | Standard Deviation 0.2 | unitless |
| Urinary pH Parameters | Allocated to Pragmatic Control | Baseline | 5.3 | Standard Deviation 0.2 | unitless |
| Urinary pH Parameters | Allocated to Intervention/Treatment | End of Study (18 months) | 6.2 | Standard Deviation 0.5 | unitless |
| Urinary pH Parameters | Allocated to Pragmatic Control | End of Study (18 months) | 5.5 | Standard Deviation 0.5 | unitless |
| %Hemoglobin A1c | Allocated to Intervention/Treatment | Baseline | 6.6 | Standard Deviation 1.4 | percentage of glycated hemoglobin |
| %Hemoglobin A1c | Allocated to Pragmatic Control | Baseline | 6.2 | Standard Deviation 0.9 | percentage of glycated hemoglobin |
| %Hemoglobin A1c | Allocated to Intervention/Treatment | End of Study (18 months) | 6.4 | Standard Deviation 1.5 | percentage of glycated hemoglobin |
| %Hemoglobin A1c | Allocated to Pragmatic Control | End of Study (18 months) | 6.7 | Standard Deviation 1.5 | percentage of glycated hemoglobin |
| Urinary Citrate Parameters | Allocated to Intervention/Treatment | Baseline | 634 | Standard Deviation 289 | mg/day |
| Urinary Citrate Parameters | Allocated to Pragmatic Control | Baseline | 673 | Standard Deviation 526 | mg/day |
| Urinary Citrate Parameters | Allocated to Intervention/Treatment | End of Study | 309 | Standard Deviation 81 | mg/day |
| Urinary Citrate Parameters | Allocated to Pragmatic Control | End of Study | 951 | Standard Deviation 782 | mg/day |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04621929/results